The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The feasibility and tolerability of anlotinib plus PD-1 blockades among patients with previously immunotherapy treated advanced esophageal squamous cell carcinoma (ESCC): Update results of a retrospective exploratory study.
 
Jing Huang
No Relationships to Disclose
 
Yong-Gui Hong
No Relationships to Disclose
 
Jun Liu
No Relationships to Disclose
 
Ping Lu
No Relationships to Disclose
 
Zhiwei Chang
No Relationships to Disclose
 
Guifang Zhang
No Relationships to Disclose
 
Xiumei Ma
No Relationships to Disclose
 
Wei Liang
No Relationships to Disclose
 
Yongjing Tian
No Relationships to Disclose
 
Jin Xia
No Relationships to Disclose
 
Heng Cao
No Relationships to Disclose